Ultimovacs to Present Poster at the American Association for Cancer Research (AACR) Annual Meeting 2024   -April 04, 2024 at 01:00 am EDT : vimarsana.com

Oslo, April 4, 2024: Ultimovacs ASA , a clinical-stage biotechnology company developing immunotherapeutic cancer vaccines, today announces that the data from the TENDU-101 study in patients with...

Related Keywords

United States , Oslo , Norway , San Diego , California , Norwegian , American , Sara Mangsbo , American Association For Cancer Research , Euronext Oslo Stock Exchange , Oslo University Hospital , Cancer Research , First In Human Phasei Clinical Trials , Monday April , Poster Section , Board Number , Abuse Regulation , Norwegian Securities Trading ,